HyProCure is a talotarsal stabilization device used in the treatment of talotarsal dislocation and resulting sequela. The implant is designed to stabilize the talus on the tarsal mechanism to prevent excessive anterior, and/or medial, and/or plantarflexion of the talus on the tarsal mechanism, while allowing normal talotarsal joint motion.
Recurrent talotarsal joint displacement (RTTJD) is a dynamic deformity where the talus repeatedly dislocates on the tarsal mechanism during weightbearing activities. RTTJD is the leading underlying etiology to the majority of lower extremity musculoskeletal disorders. People won’t outgrow this pathologic deformity and there are no case studies
presenting evidence that the TTJ will realign itself over time.
The stabilization of the TTJ while still allowing, as close as possible, a normal amount of range of motion (ROM), has to be a primary consideration in eliminating the underlying cause of chronic musculoskeletal deformities.
While there are patients who get relief from arch supports, there are others whose foot structure requires osseous reconstruction. However, between these two groups are a significant number of patients who find arch supports just aren’t enough and reconstructive surgery is simply too aggressive. These patients may be candidates for Extra-Osseous
RTTJD TaloTarsal Stabilization (EOTTS) with HyProCure®.
RegJoint™ is indicated for arthroplasties in small joints in hand and foot for patients suffering of rheumatoid arthritis or osteoarthritis. The specific target joints are metatarsal I-V, V (MTI I-V) in foot, carpometacarpal (CMC I) and metacarpophalangeal II-V (MCP II-V) joints in hand.
ul. Mławska 13
81-204 Gdynia, Poland
phone: +48 58 776 22 75
fax: +48 58 350 97 57
mobile: +48 506 399 272
Number: PL 92 1020 1853 0000 9502 0124 1017
Bank PKO BP SA, I Oddział w Gdyni
Kod BIC (Swift): BPKOPLPW